Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LY6K - Pretreatment breast needle biopsies of locally advanced breast cancer
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LY6K - Staufen1 deletion effect on mRNA abundance in HeLa cells
LY6K - Claudin-1 overexpression effect on lung adenocarcinoma cell line
LY6K - Optineurin depletion
LY6K - Tumorigenic breast cancer cells (HG-U133B)
LY6K - Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133B)
LY6K - Hutchinson-Gilford progeria syndrome: fibroblast (HG-U133B)
LY6K - Cystic fibrosis pathology and 4-phenylbutyrate (HG-U133B)
LY6K - Bone marrow stromal cell lines
LY6K - In vitro myoblast differentiation: time course
LY6K - Breast cancer metastases from different anatomical sites: fine-needle aspiration biopsies
GEO DataSets Gene Chromosome neighbors Homologene neighbors
LY6K - BRCA1 depletion effect on HeLa cells
LY6K - NCI-60 cancer cell line panel
LY6K - Alkylphospholipids effect on HaCaT keratinocytes
LY6K - Epidermal stem cell and transit-amplifying cell (HG-U133B)
LY6K - Basal-like breast cancer tumors
LOC100288181 - Androgen sensitive and insensitive prostate cancer cell lines: expression profiles
LY6K - Bone marrow mesenchymal stromal cells from primary myelofibrosis patients
LY6K - TRPV1 activation effect on epithelial cell line
LY6K - Hepatocyte growth factor treatment of prostate cancer DU145 cell line: time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on